Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL289718 | 0.86 | SMN1; SMN2 (0.48) | SMN1; SMN2CA1CA2CA7CA9 | |
| SCHEMBL1848425 | 0.85 | KMT2A (0.45) | SMN1; SMN2CA1CA2CA7CA9 | |
| SCHEMBL4621512 | 0.85 | SMN1; SMN2 (0.44) | SMN1; SMN2CA1CA2CA7CA9 | |
| SCHEMBL7227165 | 0.84 | SMN1; SMN2 (0.42) | SMN1; SMN2CA1CA2CA7CA9 | |
| SCHEMBL6501888 | 0.82 | SMN1; SMN2 (0.41) | SMN1; SMN2CA1CA2CA7CA9 | |
| SCHEMBL25962740 | 0.81 | SMN1; SMN2 (0.48) | SMN1; SMN2CA1CA2CA7CA9 | |
| SCHEMBL25434306 | 0.78 | CA1 (0.61) | SMN1; SMN2CA1CA2CA7CA9 | |
| SCHEMBL151213 | 0.78 | CA1 (0.61) | SMN1; SMN2CA1CA2CA7CA9 | |
| SCHEMBL27753904 | 0.78 | CA1 (0.61) | SMN1; SMN2CA1CA2CA7CA9 | |
| SCHEMBL23808 | 0.77 | CA1 (0.68) | SMN1; SMN2CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260150574-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2026-05-28 | — | — | US | disclosed |
| EP-4709724-A1 | ANTICONVULSIVE COMPOUNDS AND USES THEREOF | Jazz Pharmaceuticals Research UK Limited (GB) | 2026-03-18 | — | — | EP | disclosed |
| US-12428429-B2 | Amine compound and organic light-emitting diode including same | SFC CO., LTD. (KR) | 2025-09-30 | — | — | US | disclosed |
| US-12402529-B2 | Organic compound, composition, organic optoelectronic device, and display device | SAMSUNG SDI CO., LTD. (KR) | 2025-08-26 | — | — | US | disclosed |
| US-20250002519-A1 | NOVEL PRECATALYST SCAFFOLDS FOR CROSS-COUPLING REACTIONS, AND METHODS OF MAKING AND USING SAME | UNIV YALE (US) | 2025-01-02 | — | — | US | disclosed |
| WO-2024236275-A1 | ANTICONVULSIVE COMPOUNDS AND USES THEREOF | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (GB) | 2024-11-21 | — | — | WO | disclosed |
| US-12071445-B2 | Precatalyst scaffolds for cross-coupling reactions, and methods of making and using same | YALE UNIVERSITY (US) | 2024-08-27 | — | — | US | disclosed |
| EP-4389755-A1 | FLUORESCENT COMPOUND AND FLUORESCENCE-LABELED BIOSUBSTANCE OBTAINED USING SAME | FUJIFILM Corporation (JP) | 2024-06-26 | — | — | EP | disclosed |
| US-20240110918-A1 | FLUORESCENT COMPOUND AND FLUORESCENTLY LABELED BIOLOGICAL SUBSTANCE USING THE SAME | FUJIFILM CORPORATION (JP) | 2024-04-04 | — | — | US | disclosed |
| EP-3792989-B1 | ORGANIC LIGHT EMITTING DIODE INCLUDING BORON COMPOUNDS | SFC CO LTD (KR) | 2024-03-06 | — | — | EP | disclosed |
| US-6403584-B1 | CONJUNCTIVITIS, ALLERGIC RHINITIS, ALZHEIMER'S DISEASE, ASTHMA, ATHEROSCLEROSIS, AUTOLOGOUS BONE MARROW TRANSPLANTATION, ANTIINFLAMMATORY, ETC | MERCK & CO., INC. | 2002-06-11 | — | — | US | disclosed |
| EP-1203766-A2 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2002-05-08 | — | — | EP | disclosed |
| EP-1196640-A2 | ELECTRON-DEFICIENT NITROGEN HETEROCYCLE-SUBSTITUTED FLUORESCEIN DYES | Applera Corporation (US) | 2002-04-17 | — | — | EP | disclosed |
| US-20020037909-A1 | Enamine derivatives | UCB PHARMA S.A. (BE) | 2002-03-28 | — | — | US | disclosed |
| WO-2001079173-A2 | ENAMINE DERIVATIVES AS CELL ADHESION MOLECULES | CELLTECH R & D LIMITED (GB) | 2001-10-25 | — | — | WO | disclosed |
| US-20010020017-A1 | Squaric acid derivatives | CELLTECH R&D LIMITED (GB) | 2001-09-06 | — | — | US | disclosed |
| WO-2001057264-A2 | ELECTRON-DEFICIENT NITROGEN HETEROCYCLE-SUBSTITUTED FLUORESCEIN DYES | APPLERA CORPORATION (US) | 2001-08-09 | — | — | WO | disclosed |
| WO-2001047867-A1 | SQUARIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS | CELLTECH R & D LIMITED (GB) | 2001-07-05 | — | — | WO | disclosed |
| US-6221604-B1 | CONJUGATED TO SUBSTRATES SUCH AS NUCLEOSIDES OR NUCLEOTIDES AND USED AS DETECTION LABELS IN MOLECULAR BIOLOGY EXPERIMENTS; ENERGY TRANSFER DYE | PE CORPORATION | 2001-04-24 | — | — | US | disclosed |
| WO-2000071572-A1 | SUBSTITUTED BETA-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS | MERCK & CO., INC. (US) | 2000-11-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250002519-A1 | NOVEL PRECATALYST SCAFFOLDS FOR CROSS-COUPLING REACTIONS, AND METHODS OF MAKING AND USING SAME | TIMCC, YAP1, TET2 | SMN1; SMN2 2929/4885CA1 44/4885CA2 93/4885 |
| US-20240110918-A1 | FLUORESCENT COMPOUND AND FLUORESCENTLY LABELED BIOLOGICAL SUBSTANCE USING THE SAME | F11, NPFFR1, FGF23 | SMN1; SMN2 3176/4885CA1 485/4885CA2 476/4885 |
| US-20020037909-A1 | Enamine derivatives | CCR1, ITGB2, CCR10 | SMN1; SMN2 3892/4885CA1 4444/4885CA2 2933/4885 |
| US-20010020017-A1 | Squaric acid derivatives | SUCNR1, HCAR1, CCR1 | SMN1; SMN2 1016/4885CA1 2102/4885CA2 572/4885 |
| US-12428429-B2 | Amine compound and organic light-emitting diode including same | MAOA, AOC2, MAOB | SMN1; SMN2 586/4885CA1 4475/4885CA2 4780/4885 |
| US-12402529-B2 | Organic compound, composition, organic optoelectronic device, and display device | OCIAD1, OXER1, OR10J3 | SMN1; SMN2 3621/4885CA1 1374/4885CA2 1556/4885 |
| US-12071445-B2 | Precatalyst scaffolds for cross-coupling reactions, and methods of making and using same | TIMCC, YAP1, TET2 | SMN1; SMN2 3274/4885CA1 44/4885CA2 108/4885 |
| US-20260150574-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | OXER1, OR10J3, OPRD1 | SMN1; SMN2 2663/4885CA1 2395/4885CA2 2350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.